Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 24, 2025 12:06 ET | Source: Research and Markets

Duchenne Muscular Dystrophy Drugs Market 2025-2033 with Profiles of Leading Players FibroGen, Italfarmaco, NS Pharma, PTC Therapeutics, Santhera Pharmaceuticals and Sarepta Therapeutics

Dublin, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy Drugs Market by Product Type, Therapeutic Approach, End User, and Region 2025-2033" report has been added to ...
April 29, 2024 09:45 ET | Source: Research and Markets

Global Duchenne Muscular Dystrophy Drugs Market Set to Reach $ 5.5 Billion by 2032, With a CAGR of 10.17% Driven by New Product Approvals, Launches, and a Favorable Landscape

Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global Duchenne Muscular Dystrophy Drugs Market by Product Type, Therapeutic Approach, End User, and Region 2024-2032" report has been added to ...
January 26, 2023 11:03 ET | Source: Research and Markets

Global Duchenne Muscular Dystrophy Drugs Business Report 2023: Market to Reach $18.1 Billion by 2030, Growing at a Staggering CAGR of 42.5%

Dublin, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Duchenne...
February 16, 2022 05:35 ET | Source: Vantage Market Research

Global Dystrophin Market to Reach USD 30.22 Billion by 2028 - Heavy Research & Development to Boost the Market Demand – Vantage Market Research

WASHINGTON, Feb. 16, 2022 (GLOBE NEWSWIRE) -- The Global Dystrophin Market size is expected to reach USD 30.22 Billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 45.9% during the...
December 17, 2021 07:03 ET | Source: Research and Markets

Global Duchenne Muscular Dystrophy (DMD) Epidemiology Landscape Report, 2021-2030: Total, Age-specific, Ambulatory & Non-ambulatory, Mutation-specific, and Associated Comorbidities Population

Dublin, Dec. 17, 2021 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy - Epidemiology Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers...
November 03, 2021 05:23 ET | Source: Research and Markets

Duchenne Muscular Dystrophy Worldwide Outlook to 2030: Upcoming Strategies Include Gene Therapy and Cell Therapy

Dublin, Nov. 03, 2021 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy - Market Insight, Epidemiology and Market Forecast -2030" report has been added to ResearchAndMarkets.com's offering. Key...